The Latest SPAC News and Rumors: October 11, 2022
by Marlena Haddad on 2022-10-11 at 11:37am


Below is a daily summary of links to the latest SPAC news and rumors gathered across the web. 

Latest SPAC News:  LanzaTech produces ethylene from CO2, Selina provides first half 2022 earnings results, and Footprint partners with SAMBAZON


LanzaTech Produces Ethylene from CO2, Changing the Way We Make Products Today

LanzaTech NZ, Inc. (“LanzaTech”), an innovative Carbon Capture and Transformation (“CCT”) company that transforms waste carbon into materials such as sustainable fuels, fabrics, packaging, and other products that people use in their daily lives, today announced it has successfully engineered specialized biocatalysts to directly produce ethylene from CO2 in a continuous process.

As announced on March 8th, 2022, LanzaTech has entered into a merger agreement with AMCI Acquisition Corp. II (Nasdaq: AMCI).

READ

Selina Provides First Half 2022 Earnings Results and Update on Business Combination

Selina, the fast-growing lifestyle and experiential hospitality brand targeting Millennial and Gen Z travelers, today announced financial results for the business for the first half of 2022 and provided an update on its proposed business combination with BOA Acquisition Corp (NYSE: BOAS) which would result in the Company becoming publicly traded.

In the first half of 2022, Selina delivered record revenue of $86 million, up 142% year-over-year, driven primarily by improved operating performance across the existing portfolio, as well as 13 new openings.

READ

Footprint and SAMBAZON Partner to Develop Plastic-Free Frozen Acai Bowls

Footprint, a global materials science technology company focused on creating a healthier planet, announced today a multi-year agreement to develop sustainable packaging for SAMBAZON, a leading supplier of certified fair trade and organic açaí. The partnership will leverage Footprint’s proprietary technology to bring plant-based fiber solutions to market for application in SAMBAZON’s ready-to-eat açaí bowls, a frozen product with a fifteen-month shelf life.

In December 2021, Footprint announced its intention to list on NASDAQ as a public company in a business combination agreement with Gores Holdings VIII, Inc. (Nasdaq: GIIX, GIIXW and GIIXU).

READ

 

Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved